Mitral Regurgitation
Conditions
Brief summary
The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.
Interventions
Patients will undergo clinical and echocardiographic examination including detailed 3D echocardiography at study inclusion and at least one follow-up visit.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patients with primary or secondary mitral regurgitation (MR) * MR of moderate or severe degree * 3D echocardiographic examinations of \>= good spatial and temporal resolution
Exclusion criteria
* Co-existence of another valve disease of severe degree * Inability to give informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Major cardiovascular event | 24 months | Death, mitral valve intervention, heart failure hospitalization |
Secondary
| Measure | Time frame |
|---|---|
| All-cause death | 24 months |
| Cardiovascular death | 24 months |
| Mitral valve intervention | 24 months |
Countries
Norway